Mark S. Link
Cardiology and Cardiovascular Medicine · 2000–2022
A researcher in the Science corpus: 20 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 251 citations into it; #832 of 906 by trust here, #71 by citations
Whom Mark S. Link trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mark S. Link overall
Papers from Mark S. Link's perspective
Ordered by how strongly the researchers Mark S. Link trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonparametric Estimation from Incomplete Observations
- Short QT Syndrome: A Familial Cause of Sudden Death (Circulation)
- Triggering of sudden death from cardiac causes by vigorous exertion. (New England Journal of Medicine)
- Hypertrophic cardiomyopathy.
- Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. (New England Journal of Medicine)
- Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. (New England Journal of Medicine)
- Brugada syndrome: report of the second consensus conference. (Heart Rhythm)
- Hyperventilation-Induced Hypotension During Cardiopulmonary Resuscitation (Circulation)
- Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. (New England Journal of Medicine)
- Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)
Their papers
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) — 899 citations
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) — 794 citations
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) — 717 citations
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) — 4,324 citations
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2020) — 818 citations
- Part 1: Executive Summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. (2015) — 752 citations
- Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. (2015) — 1,151 citations
- 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2013) — 1,418 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 1,435 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci (2011) — 1,097 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 937 citations
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 848 citations
- Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. (2010) — 1,023 citations
- Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. (2010) — 2,000 citations
- Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. (2010) — 821 citations
- Recommendations for interpretation of 12-lead electrocardiogram in the athlete. (2009) — 792 citations
- Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. (2007) — 715 citations
- Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. (2007) — 940 citations
- Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction (2006) — 924 citations
- Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. (2000) — 987 citations